Development of artificial muscles based on electroactive ionomeric polymer-metal composites.

This work contextualizes the research of materials that can be applied as artificial muscles. The main motivation of this research is the importance of the development of mechatronic systems for the replacement of traditional devices of actuation and motion based on rotational electrical motors by other devices that reproduce biological muscle movements. Electroactive polymers (EAPs) are materials that respond to electric stimuli with shape and/or dimension changes, and accomplish movements that are smooth enough to mimic biological muscles. Among EAPs, the ionomeric polymer-metal composites (IPMCs) are an interesting alternative to biomimetic devices due to large displacements when submitted to low applied voltage. This article presents a brief review of IPMCs, a sample preparation procedure, and some electromechanical experimental results. We also discuss the applicability of this technology in medical devices and as artificial muscles.

Identification of Microthoracius mazzai (Phthiraptera: Anoplura) as an economically important parasite of alpacas.

The hematophagous sucking louse Microthoracius mazzai Werneck, 1932, is redescribed and identified as a parasite of alpacas, Lama pacos L. Specimens were collected on animals 10-14 mo old, located on a large community farm at 4,600 m above sea level in the Peruvian Andes. In total, 26 scanning electron microscope (SEM) figures are included that highlight salient and differential characteristics, especially the unique elongated spindle-shaped head, which is almost as long as its abdomen. Alpacas, 1 of the 4 species of South American camelids, are important for their production of high-quality wool in the Andes Mountain range countries, especially Peru and Bolivia; to a lesser degree Chile; and more recently Argentina, where breeding and disease control programs are receiving increased technical support. Information is given on the prevalence of lice infestations in the flock, clinical signs, and economic losses. We report the efficacy of moxidectin (SC, 200 mcg/kg, b.w.) in a repeated treatment program of 7-10 d, which is currently used for mange control in these ruminants.